Popular Posts

▼

Tuesday, April 04, 2017

Class action lawsuit filed against Mylan over EpiPen pricing

WASHINGTON (Sinclair Broadcast Group) - The company that increased a branded 2-Pak version of the Epipen shot to more than $600 is facing a class action lawsuit.

According to a press release by law firm Hagens Berman, a group of purchasers believes Mylan "engaged in an illegal organized scheme to systematically increase EpiPen prices by 574 percent."

The complaint states that since Mylan secured the rights to distribute the life-saving drug in 2007, it increased prices 17 times from $90.28 to $608.62.

“Mylan has tried every trick in the book to avoid taking accountability for the millions of people who are living without the EpiPen they need to prevent a life-threatening allergic reaction," Steve Berman stated.

More
at

4 comments:

  1. AnonymousApril 4, 2017 at 7:07 PM

    this is the best news ever!
    people are tired of being screwed

    ReplyDelete
  2. AnonymousApril 4, 2017 at 9:51 PM

    LOL! The only people that get paid in a class action are the lawyers on both sides. Consumers get pennies on the dollar.

    ReplyDelete
  3. AnonymousApril 4, 2017 at 10:08 PM

    Thieves.

    ReplyDelete
  4. AnonymousApril 5, 2017 at 9:59 AM

    The main point isn't to get damages for the users, it's to lower the price to something reasonable.

    ReplyDelete

Note: Only a member of this blog may post a comment.